Natdac (Daclatasvir 60mg)is a hepatitis C virus (HCV) NS5A inhibitor indicated for use with sofosbuvir, with or without ribavirin, for the treatment of chronic HCV genotype 1 or 3 infection. Limitations of Use:

1.Sustainedvirologicresponse(SVR12)ratesarereducedingenotype3patientswith cirrhosis receiving Daclatasvir 60mg in combination with sofosbuvir for 12 weeks.


There are no reviews yet.

Be the first to review “Buy Natdac (DAKLINZA) Daclatasvir 60mg Online”

Your email address will not be published. Required fields are marked *